Medical Services Expenditures by Disease: Complications of Pregnancy; Childbirth; and the Puerperium, MEPS Account Basis (COPRCHEXPMEPS) | FRED | St. Louis Fed
- Rows
- 22
- Columns
- 2
- Data range
- 2000-01-01 to 2021-01-01
Graph and download economic data for Medical Services Expenditures by Disease: Complications of Pregnancy; Childbirth; and the Puerperium, MEPS Account Basis (COPRCHEXPMEPS) from 2000 to 2021 about pregnancy, disease, healthcare, medical, birth, health, expenditures, services, and USA.
AI analysis
Data Analysis: Medical Services Expenditures for Pregnancy/Childbirth Complications (COPRCHEXPMEPS)
1. Dataset Overview and Value
This series, sourced from FRED (Federal Reserve Bank of St. Louis) via the Medical Expenditure Panel Survey (MEPS) account basis, tracks annual expenditures on medical services related to complications of pregnancy, childbirth, and the puerperium (postpartum period) in the USA from 2000–2021. The source URL (fredgraph.csv API endpoint) confirms this is a programmatically accessible, authoritative government-adjacent series maintained by FRED, which typically updates such MEPS-derived series annually with a lag of 1-2 years — meaning 2021 is likely near the current data frontier for this series. As a long-run annual time series (22 observations), it's well-suited for macro-level correlation studies against other healthcare cost indices, demographic trends (e.g., birth rates), insurance coverage metrics, or broader CPI/medical inflation series, though its low observation count limits statistical power for complex multivariate models.
2. Data Quality Observations
The dataset is remarkably clean at face value: zero null cells across both columns, and the join key (observationdate) shows 22 distinct values matching the 22 total rows — indicating no duplicate timestamps and a complete, gapless annual series from 2000 to 2021. No column shows disproportionate nulls since null counts are uniformly zero. The main caveat is that duplicate-row deduplication and Parquet-based verification are still pending ("Phase D" not yet complete), so while surface-level integrity looks solid, final confirmation of row-level uniqueness awaits backend reconciliation. Given the small size (22 rows, 2 columns), this is a low-risk dataset from a quality-management perspective — there's little scope for hidden data integrity issues beyond what's already been checked.
3. Key Column Distributions
The expenditure column (COPRCHEXPMEPS) ranges from 42.23 to 94.88 (units likely in millions or billions of dollars, unspecified in metadata — worth verifying against the FRED page), with a mean of 67.23 and median of 67.58, indicating a fairly symmetric distribution. This is reinforced by a skewness of -0.124, showing only slight left-skew (near-normal). The interquartile range (Q1=54.59, Q3=80.23) spans about 25.6 units, consistent with the overall range of ~52.65, suggesting no extreme outliers and a reasonably even spread of values across the two-decade period — likely reflecting a steady upward trend typical of healthcare cost series, though the moderate standard deviation (σ=15.46, ~23% of the mean) indicates meaningful year-over-year variability worth plotting as a time series to detect inflection points (e.g., post-2008 recession or ACA implementation effects around 2010-2014).
4. Recommended Join Keys
observationdate is the clear and only viable join key — it's a clean annual date field (Jan 1 of each year, 2000–2021) with zero nulls and full distinctness. For cross-dataset correlation, this should be matched against other annual (or resampled-to-annual) time series using the same date convention. Analysts should confirm whether comparison datasets use calendar-year timestamps or fiscal-year conventions, and standardize granularity (e.g., aggregating monthly/quarterly data to annual) before joining.
5. Suggested Complementary Datasets
Strong correlation candidates include: (a) other MEPS disease-expenditure series (e.g., diabetes, cardiovascular disease, mental health) to compare relative cost growth across conditions; (b) CDC/NCHS birth rate and fertility rate data to test whether expenditure trends track birth volume or reflect rising per-case treatment costs; (c) CPI for Medical Care (CPIMEDSL) or Personal Health Care Expenditures from BEA/CMS to contextualize whether this series outpaces general healthcare inflation; (d) health insurance coverage rates (e.g., uninsured rate, Medicaid expansion timing by state) to explore policy-driven cost shifts, especially around the 2010 ACA passage; and (e) maternal mortality/morbidity rates from CDC to investigate whether expenditure increases correlate with health outcome improvements or worsening complication severity.
Columns
- observation_date (date)
- COPRCHEXPMEPS (decimal)